ArticleNaunyn-Schmiedeberg's archives of pharmacology2014

A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway.

Jui-Ling Hsu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.